Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry – is dosing according to renal function appropriate? von Camm, A.J, Virdone, S, Fox, K.A.A, Pieper, K.S, Beyer-Westendorf, J, Le Heuzey, J.-Y, Haas, S, Kayani, G, Gersh, B.J, Turpie, A.G.G, Kakkar, A.K

Volltext

Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry von Beyer-Westendorf, J, Camm, A.J, Virdone, S, Fox, K.A.A, Pieper, K.S, Le Heuzey, J.-Y, Haas, S, Kayani, G, Gersh, B.J, Turpie, A.G.G, Kakkar, A.K

Volltext

Impact of NOAC and VKA on outcome of patients with newly diagnosed atrial fibrillation and diabetes: a report from the GARFIELD-AF registry von Bassand, J, Virdone, S, Verheugt, F.W.A, Camm, A.J, Cools, F, Fox, K.A.A, Goldhaber, S.Z, Goto, S, Haas, S, Hacke, W, Kayani, G, Misselwitz, F, Pieper, K.S, Turpie, A.G.G, Kakkar, A.K

Volltext

Safety and efficacy of apixaban and rivaroxaban versus warfarin in real-world atrial fibrillation patients are similar to their randomized trials: insights from GARFIELD-AF registr... von Himmelreich, J.C.L, Virdone, S, Camm, A.J, Harskamp, R.E, Pieper, K.S, Fox, K.A.A, Bassand, J.-P, Fitzmaurice, D.A, Goldhaber, S.Z, Goto, S, Haas, S, Misselwitz, F, Turpie, A.G.G, Verheugt, F.W.A, Kakkar, A.K

Volltext

Comparing rivaroxaban and apixaban in GARFIELD-AF according to ROCKET AF and ARISTOTLE trial selection criteria von Himmelreich, J.C.L, Virdone, S, Camm, A.J, Harskamp, R.E, Pieper, K.S, Fox, K.A.A, Bassand, J.-P, Fitzmaurice, D.A, Goldhaber, S.Z, Goto, S, Haas, S, Misselwitz, F, Turpie, A.G.G, Verheugt, F.W.A, Kakkar, A.K

Volltext

Comparative effectiveness of NOAC vs VKA in patients representing common clinical challenges: results from the GARFIELD-AF registry von Virdone, S, Himmelreich, J.C.L, Pieper, K.S, Camm, A.J, Bassand, J.-P, Fox, K.A.A, Fitzmaurice, D.A, Goldhaber, S.Z, Goto, S, Haas, S, Kayani, G, Misselwitz, F, Turpie, A.G.G, Verheugt, F.W.A, Kakkar, A.K

Volltext

The effect of body mass index on clinical outcomes in patients with newly diagnosed atrial fibrillation in the GARFIELD-AF registry von Camm, C.J.F, Camm, A.J, Virdone, S, Bassand, J.-P, Fitzmaurice, D.A, Fox, K.A.A, Goldhaber, S.Z, Goto, S, Haas, S, Turpie, A.G.G, Verheugt, F.W.A, Misselwitz, F, Kayani, G, Pieper, K.S, Kakkar, A.K

Volltext

Clinical outcomes of patients with newly diagnosed atrial fibrillation who refused anticoagulation: findings from the global GARFIELD-AF registry von Apenteng, P, Fitzmaurice, D.A, Virdone, S, Camm, A.J, Fox, K.A.A, Bassand, J.-P, Goldhaber, S.Z, Goto, S, Haas, S, Turpie, A.G.G, Verheugt, F.W.A, Misselwitz, F, Kayani, G, Pieper, K.S, Kakkar, A.K

Volltext

Permanent discontinuation of different anticoagulants in patients with atrial fibrillation and the impact on clinical outcome: data from the GARFIELD-AF registry von Cools, F, Johnson, D, Pieper, K.S, Camm, A.J, Bassand, J.-P, Fitzmaurice, D.A, Fox, K.A.A, Goldhaber, S.Z, Goto, S, Haas, S, Turpie, A.G.G, Verheugt, F.W.A, Misselwitz, F, Kayani, G, Kakkar, A.K

Volltext

Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF von Camm, A.J, Steffel, J, Virdone, S, Bassand, J.-P, Fitzmaurice, D.A, Fox, K.A.A, Goldhaber, S.Z, Goto, S, Haas, S, Turpie, A.G.G, Verheugt, F.W.A, Misselwitz, F, Kayani, G, Pieper, K.S, Kakkar, A.K

Volltext

P4603The burden of atrial fibrillation in the more populated European countries: perspectives from the GARFIELD-AF registry von Mantovani, L., Cozzolino, P., Angiolella, L.D.', Agnelli, G., Ambrosio, G., Camm, A.J., Darius, H., Fitzmaurice, D.A., Fox, K.A.A., Kayani, G., Keltai, M., Le Heuzey, J.-Y., Pieper, K.S., Kakkar, A.K.

Volltext

Heart failure post-myocardial infarction in the new millennium: how often does it occur, can we predict it, and what are the consequences? von Lewis, E.F., Velazquez, E.J., McMurray, J.J.V., Rouleau, J.L., Solomon, S.D., Maggioni, A.P., Swedberg, K., Kober, L., White, H., Dalby, A.J., Francis, G.S., Pieper, K.S., Zannad, F., Califf, R.M., Pfeffer, M.A.

Volltext

The Effect of Metabolic Milieu on Cardiac PET Imaging Using Fluorine-18-Deoxyglucose and Nitrogen-13-Ammonia in Normal Volunteers von Berry, Jonathan J, Baker, Jay A, Pieper, Karen S, Hanson, Michael W, Hoffman, John M, Coleman, R. Edward

Volltext

The myocardial collagenous connective tissue in experimental cardiac hypertrophy induced by swimming exercise and hypertension von Kunz, J., Braselmann, H., Gottschalk, J., Kreher, CH, Pieper, K.S.

Volltext

Antimullerian hormone (AMH): how high is too high? a 2012-2014 national study von Acharya, K.S., Harris, B.S., Truong, T., Lerebours, R., Pieper, C.F., Eaton, J.L.

Volltext

Can a high AMH overcome advancing reproductive age? the association between AMH and live birth rate among women over age 40 von Harris, B.S., Acharya, K.S., Truong, T., Lerebours, R., Pieper, C.F., Eaton, J.L.

Volltext